Are Peptides Legal to Sell in the United States?
The short answer: yes, but with significant qualifications. Selling peptides online in the U.S. is legal when the products are marketed correctly, the business complies with federal and state regulations, and the seller avoids claims that would classify their products as drugs or controlled substances. The longer answer involves understanding the distinction between research peptides, cosmetic peptides, and therapeutic peptides — and why that distinction determines whether your business can accept credit card payments.
The question "are peptides legal?" generates over 3,600 searches per month because the answer is genuinely complex. It is not a simple yes or no — it depends on what peptides you sell, how you market them, and what claims you make.
The Legal Framework for Peptide Sales
Federal law
Peptides are not scheduled as controlled substances under federal law (with rare exceptions, discussed below). The Controlled Substances Act does not list peptides as a category. This means manufacturing, selling, and purchasing most peptides is not inherently illegal at the federal level.
However, the regulatory framework involves multiple federal agencies:
FDA (Food and Drug Administration) — The FDA regulates peptides based on how they are marketed and intended to be used. A peptide sold "for research use only" is treated differently than one marketed for human consumption or therapeutic benefit. The FDA has taken enforcement action against companies marketing peptides as dietary supplements or drugs without appropriate approvals.
DEA (Drug Enforcement Administration) — The DEA becomes involved if a specific peptide is scheduled as a controlled substance. Currently, very few peptides are scheduled, but some analogs of controlled substances may fall under the Federal Analogue Act.
FTC (Federal Trade Commission) — The FTC regulates advertising claims. Making unsubstantiated health or performance claims about peptides can trigger FTC enforcement regardless of the product's legal status.
The "research use only" framework
Most online peptide sellers operate under the "research use only" (RUO) framework. Under this model:
- Products are labeled and marketed exclusively for in-vitro research, laboratory use, or scientific investigation
- No claims are made about human consumption, therapeutic benefit, or performance enhancement
- Buyers acknowledge the research-only designation during purchase
- Product pages do not reference human dosing, cycles, or health outcomes
This framework is not explicitly defined in a single statute — it exists at the intersection of FDA guidance, FTC advertising rules, and industry practice. It works because the FDA primarily exercises enforcement discretion based on how products are marketed. A company selling BPC-157 labeled "for research purposes" with no health claims is treated very differently from a company selling the same compound marketed as a healing supplement.
Which Peptides Face Legal Restrictions?
While most peptides are legal to sell, specific categories face restrictions or heightened scrutiny:
Peptides with controlled substance analogs
Some peptides are structural analogs of controlled substances. Under the Federal Analogue Act, substances "substantially similar" to Schedule I or II drugs can be treated as controlled substances if intended for human consumption. This primarily affects certain research chemicals rather than typical research peptides, but sellers should verify that their product catalog does not include analogs of scheduled compounds.
Peptides the FDA has targeted
The FDA has issued warning letters and taken enforcement action against companies selling peptides with therapeutic claims. Key actions include:
- Warning letters to companies marketing GHK-Cu, TB-500, and BPC-157 as anti-aging or healing supplements
- Seizure actions against companies selling peptides marketed as injectable drugs
- Import alerts for peptides entering the U.S. from overseas manufacturers without proper documentation
The critical distinction: these enforcement actions targeted marketing claims and product positioning, not the peptides themselves. Selling the same compounds for research purposes without health claims has not been the subject of comparable enforcement.
State-level considerations
Most states follow federal classification — if a peptide is not federally scheduled, it is not state-scheduled. However, some states have their own analog laws or have scheduled specific compounds. Sellers should review the laws in states where they have significant customer bases or physical operations.
How Peptide Legality Affects Payment Processing
The legal gray area around peptides directly impacts payment processing. Even though selling peptides is legal, the perceived regulatory risk causes most payment processors to treat peptide businesses as high-risk.
Why mainstream processors decline peptide businesses:
- Stripe, Square, and PayPal classify peptides as restricted products. Their aggregator model does not support individual risk assessment for legally complex product categories.
- Standard acquiring banks lack underwriting expertise for peptides. When they see "peptides," they associate the category with controlled substances and issue blanket declines.
- Chargeback risk is elevated in the peptide space due to shipping issues, product expectations, and subscription billing disputes.
How compliant peptide sellers get approved:
The sellers who maintain stable payment processing are the ones who take compliance seriously:
1. Strict RUO marketing — no health claims anywhere on the site, including blog content and customer reviews 2. Third-party lab testing — Certificates of Analysis for every product, demonstrating quality and composition 3. LegitScript certification — increasingly expected by acquiring banks as an independent compliance verification 4. Proper disclaimers — age verification, research-only acknowledgment during checkout, clear terms of service 5. Specialized processor — working with a provider like Unison that has dedicated peptide underwriting and acquiring bank relationships built specifically for this category
If you are a peptide seller struggling with payment processing, our peptide payment processing guide covers the approval process in detail. For merchants who have been shut down, see what to do after a merchant account termination.
2026 Regulatory Outlook
The regulatory landscape for peptides continues to evolve. Key developments to watch:
FDA enforcement trends — The FDA has increased its focus on compounding pharmacies producing peptides for therapeutic use. This primarily affects medical providers and compounding pharmacies rather than research peptide sellers, but it has created broader awareness and scrutiny of the peptide category.
State legislation — Several states are considering bills that would regulate peptide sales more explicitly. The trend is toward regulation rather than prohibition — creating clear rules for quality standards, labeling, and sales rather than banning peptides outright.
Industry self-regulation — Organizations like the American Peptide Society and industry coalitions are working on voluntary standards that could become the basis for regulatory frameworks. Participation in these efforts positions your business favorably for whatever regulatory landscape emerges.
Payment processing evolution — As the peptide market matures and regulatory frameworks become clearer, more acquiring banks are developing kratom and peptide underwriting programs. This is gradually improving processing availability and reducing rates for compliant sellers.
For ongoing updates on peptide regulations and how they affect payment processing, see our peptide regulation news page.
Staying Compliant as a Peptide Seller
Compliance is not a one-time checkbox — it is an ongoing business practice. The peptide sellers who maintain stable operations, keep their merchant accounts, and avoid regulatory issues are the ones who build compliance into their daily operations.
Monthly compliance review checklist
- Review all product pages for language that could be interpreted as health claims
- Verify disclaimers are present and unmodified on all pages
- Check customer reviews/testimonials for health-related content and filter as needed
- Update COAs for any new product batches
- Review marketing materials (emails, social media, ads) for compliance
- Check state regulatory updates for any changes affecting your operations
Annual compliance review
- Renew LegitScript certification if applicable
- Review and update terms of service, refund policy, and shipping policy
- Audit your website for accumulated content that may have drifted from compliance standards
- Evaluate your payment processing relationship — rates, reserve status, chargeback ratios
Bottom Line
Peptides are legal to sell online in the United States when sold for research purposes, marketed without health or therapeutic claims, and compliant with federal and state regulations. The legal framework is nuanced but navigable for sellers who invest in compliance.
The biggest practical challenge is not legality — it is payment processing. Mainstream processors decline peptide businesses regardless of compliance. Working with a specialized high-risk processor that understands the peptide category is essential.
Apply for a peptide merchant account → or explore our peptide payment processing solutions to learn how Unison supports compliant peptide businesses.